Frost & Sullivan Release: Adoption of PCR across Europe Spurred by Potential to Advance Drug Discovery

LONDON--(BUSINESS WIRE)--A significant number of end users in the genomics and proteomics market are now using polymerase chain reaction (PCR) technology. While the conventional PCR technique is well established, end users are also showing increasing interest in real-time PCR.
MORE ON THIS TOPIC